3 Stocks That Were Unaffected By Hurricane Harvey
CORAL GABLES, FL / ACCESSWIRE / August 28, 2017 / On Monday, oil prices dropped, while gasoline futures hiked to their highest levels since July 2015, as energy markets roiled from the impact of Hurricane Harvey on the U.S. Gulf Coast. Harvey hit Texas this past weekend recording the most powerful hurricane to hit the state in over 50 years, killing a minimum of 2 people, and a big flooding surge. Texas is the base to 5.6 million barrels of refining capacity per day, with over 2 million barrels per day were predicted to be offline due to the storm. With that being said, here are 3 stocks to watch that were unaffected by Hurricane Harvey: Medical Imaging Corp. (MEDD), root9B Holdings, Inc. (RTNB) and Delcath Systems, Inc. (DCTH).
Medical Imaging Corp. (MEDD) is a provider of all-inclusive medical imaging services for patients and client hospitals throughout the US and Canada. Over the last two weeks (MEDD) has been trading above its 30 day average volume and has seen a price per share increase of 14.35% from lows on August 15th of $0.0787 to Friday's (8/25) closing price at $0.09.
The company recently announced that it has upgraded its CT machine at its Naples, Florida location. "Our Naples CT business has been growing throughout 2017, so it was important to have the software installed to meet the new federal standards and ensure that we had a stronger and newer CT machine with greater up time as we approach the start of our busy season this fall," quotes Mitch Geisler, CEO. "The machine has now been installed and we can resume scanning CT patients this week." Click Here For Full Report on (MEDD)
Root9B Holdings, Inc. (RTNB) is a leading provider of advanced cyber security products, services and training has been of the most trending stocks to watch in the last week of trading. The company recently announced that it has secured funding for business operations and other working capital purposes. Since the beginning of last week (8/21) (RTNB) has seen an advance in pps of 273.75% from lows on Monday (8/21) of $0.80 to pre-market highs on Monday (8/28) of $2.99.
Delcath Systems, Inc. (DCTH) is an interventional oncology company that specializes on the treatment of primary and metastatic liver cancers. On Monday morning (8/28) the company announced it had reached an agreement for the elimination of its 2016 convertible notes from the majority note holder. The agreement, if fully executed will terminate roughly 90% of the remaining debt related to the convertible notes.
"We negotiated this agreement as a means of reducing future potential dilution from the Convertible Notes after a reverse stock split. We strongly urge shareholders to vote in favor of the proposed reverse stock split as it will now trigger the extinguishment of a substantial portion of the Convertible Notes. The proposed reverse stock split will also allow us to regain compliance with the Nasdaq Minimum Bid Price, which provides liquidity and other benefits to shareholders. Additionally, we believe a successful reverse stock split will provide the Company with the flexibility to raise new equity capital at potentially more beneficial terms, allowing us to continue to support our Clinical Development Program and commercial efforts in Europe where we believe shareholder value ultimately resides," stated Jennifer K. Simpson, Ph.D., MSN, CRNP President and CEO of Delcath.
(DCTH) has been trading between the price ranges of $0.11-0.13. (DCTH) is up 11.34% from Friday's (8/25) closing price of $0.1225 to pre-market highs on Monday (8/28) of $0.1365.
For free up to the minute financial news updates, text keyword HFNEWS to 474747.
About HeraldFinance.com
HeraldFinance.com ("HF") is owned by MAD Media Publishing LLC, a Nevada corporation. HF produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. HF has not been compensated: an affiliate company of HF, MIDAM VENTURES LLC, has been compensated $150,000 by a non-affiliate 3rd party for a period beginning 8/8/2017 and ending 9/7/2017 to publicly disseminate information about MEDD. We own zero shares.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither HF nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.HeraldFinance.com/.
NO WARRANTY
HF, the Author, and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect, or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise, arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
Contact:
SOURCE: HeraldFinance.com
